Results

Total Results: 1,524 records

Showing results for "drugs".

181. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Autism treatments and drugs. [internet].

182. Misuse of Prescription Stimulants in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol-amendment.pdf
     November 26, 2024 - For example, emergency department visits related to NMU of these drugs by adults increased from 5,212 … Misuse of Prescription Drugs Research Report. 2023. … https://nida.nih.gov/publications/research-reports/misuse-prescription-drugs/overview. … MMWR https://nida.nih.gov/publications/research-reports/misuse-prescription-drugs/overview https://

183. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - Vertex Pharmaceuticals, Cystic Fibrosis Foundation. … Vertex Pharmaceuticals Incorporated, Cystic Fibrosis Foundation. … Pricing for orphan drugs: will the market bear what society cannot? … Vertex Pharmaceuticals Incorporated. … Vertex Pharmaceuticals Incorporated.

184. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_june_2012.pdf
     January 01, 2012 - In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … several weeks, following a single infusion. 37,41,42 The drug was originally launched by King Pharmaceuticals … Drugs Future 2009;34(3):217-21. 39. Thomson Reuters Integrity [database online]. … In: Drugs@FDA [internet]. Silver Spring (MD): U.S. … Available: http://www.accessdata.fda.gov/scripts/cder/drugs atfda/index.cfm?

185. Migraine-Emergency Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-emergency_executive.pdf
     November 01, 2012 - ergot derivatives (e.g., dihydroergotamine [DHE]), intravenous (IV) nonsteroidal anti-inflammatory drugs … Food and Drug Administration documents related to the drugs of interest were reviewed for additional … We recognize that many drugs have various effects. … For the mixed-treatment analysis, we identified a group of drugs that were not easily classified and … We refer to these drugs collectively as “orphan agents.”

186. Horizon-Scan Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-protocol.pdf
     December 01, 2011 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … If so, do not select, because these are “me-too” of existing drugs. … Covers future industry trends, key industry developments, research and development of drugs and pharmaceuticals … Industries covered: pharmaceuticals, biotechnology, medical equipment & devices, and in vitro diagnostics

187. Disposition of Comments Report for Treatment of Atrial Fibrillation (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation_disposition-comments.pdf
     June 28, 2013 - And for KQ4, comparing anti-arrhythmic drugs (AADs) with electrical cardioversion for restoration of … We have added additional information about whether the drugs were given IV, orally, or a combination … Mascette ES (Results) The inclusion of amiodarone and sotalol as rate-control drugs (pp. … Mascette Results A gender difference in efficacy of drugs (but not proarrhythmia) is mentioned on … Comparative efficacy of rate control drugs is a good example.

188. The Effectiveness of Disease-Modifying Antirheumatic Drugs (DMARDS) in Children With Juvenile Idiopathic Arthritis (JIA) | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/juvenile-arthritis-dmards/research-protocol

189. S158 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s158.pdf
     October 01, 2007 - Measures: Association between nonsteroidal antiinflammatory drugs (NSAIDs) and mortality. … In addition, frail elderly patients, who use the most drugs and have the highest adverse event rates, … These databases are, however, often the best source of information on the association between drugs and … diseases, because they allow timely assessment of infrequently used drugs and rare outcomes in large … Selective prescribing led to overestimation of the benefits of lipid-lowering drugs.

190. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … Results The table below lists the seven topics for which (1) preliminary phase III data on drugs or … to several weeks, following a single infusion. 29,33,34 The drug was launched in 1966 by King Pharmaceuticals … Drugs Future 2009;34(3):217-21. 31. Thomson Reuters Integrity [database online]. … In: Drugs@FDA [internet]. Silver Spring (MD): U.S.

191. Disposition of Comments for CER 208 Treatment for Bipolar Disorder in Adults A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-adults-disposition-comments.pdf
     August 07, 2018 - Introduction Peer Reviewer #6 “Drugs for acute mania are generally used for shorter periods than … drugs used for treating depression or for maintenance.” – This is often not the case. … The statement is not true of other drugs. Thank you for the clarification. … We revised the sentence to read that some drugs may increase these risks. … Perhaps for clarity “Other drugs for acute mania” could be relabeled “Drugs Not Approved by FDA For

192. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
     January 01, 2012 - Optimer Pharmaceuticals announced a 2-year agreement with Cubist Pharmaceuticals, Inc. … Tibotec Pharmaceuticals, Vertex Pharmaceuticals. … Cambridge (MA): Vertex Pharmaceuticals, Inc.; 2012 Feb 23 [accessed 2012 May 21]. [5 p]. … Cambridge (MA): Vertex Pharmaceuticals Incorporated; [accessed 2012 May 17]. [3 p]. … San Diego (CA): Optimer Pharmaceuticals, Inc.; 2011 [accessed 2011 Jul 21]. [4 p].

193. Management of Primary Headache During Pregnancy: Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/headaches-pregnancy.pdf
     March 23, 2019 - For example, nonsteroidal anti- inflammatory drugs (NSAIDs) have been shown to be associated with a higher … therapies used outside of pregnancy, such as complementary and alternative therapies and biologic drugs … Use of non-steroidal anti-inflammatory drugs in pregnancy: impact on the fetus and newborn. … https://www.fda.gov/drugs/drugsafety/ucm350684.htm. Accessed on March 23, 2019. … https://www.fda.gov/drugs/drugsafety/ucm350684.htm 19 16. Andrade C.

194. Point-Of-Care Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/point-of-care_research.pdf
     April 01, 2014 - We typically did not review evidence summaries on specific interventions, such as specific drugs or … Dietary Supplements in Adults Taking Cardiovascular Drugs. … Interactions of commonly used dietary supplements with cardiovascular drugs: a systematic review. … Dietary Supplements in Adults Taking Cardiovascular Drugs. … Interactions of commonly used dietary supplements with cardiovascular drugs: a systematic review.

195. Arthritis-Psoriatric Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_executive.pdf
     April 01, 2012 - Available therapies for PsA include corticosteroids, oral disease-modifying antirheumatic drugs or … Effective Health Care infliximab) are also classified as antitumor necrosis factor (anti-TNF) drugs … Finally, very little is known about the benefits or risks of these drugs in different patient subgroups … Analytic framework for treatment for psoriatic arthritis DMARDS = disease-modifying antirheumatic drugs … Discussion No head-to-head controlled trials meeting inclusion criteria existed for any drugs in this

196. Treatment for Restless Legs Syndrome Disposition of Comments Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_disposition-comments.pdf
     November 27, 2012 - Peer Reviewer #1 Introduction The gabapentin- pregabalin group of drugs is called “GABA analogs”. … This complication can occur in 9- 17% of RLS patients using these drugs. … First, FDA approved drugs include rotigotine (probably approved after submission) and gabapentin enacarbil … was not identified as a therapy commonly used and we identified no eligible studies examining these drugs … Since most of the report does not actually compare drugs, why can these not be included?

197. Newer Medications for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostatic-hyperplasia-medications_research-protocol.pdf
     April 21, 2015 - Prescribing behavior has changed with the approval of new drugs and the availability of new evidence … for efficacy, comparative effectiveness, and harms.6 Table 1 provides a list of drugs commonly used … and enlarged prostates with either agent are supported by systematic reviews.10, 13 Recently, newer drugs … A new AB, silodosin, was approved for the treatment of BPH in 2008.7 Several anticholinergics drugs … symptoms such as urgency, frequency, and nocturia, which may or may not be causally related.15 These drugs

198. ADHD Medications and Risk of Serious Coronary Heart Disease in Yough and Middle-Aged Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-children_research.pdf
     January 01, 2023 - The study drugs included all medications with a label indication for treatment of ADHD as of December … Study Medications ADHD medications and other drugs of interest were identified from pharmacy records … person-day of follow-up for cohort members was classified according to probable use of study ADHD drugs … ADHD drugs and cardiovascular risk. N Engl J Med 2006 Apr 6;354(14):1445-8. 6. … Atypical antipsychotic drugs and the risk of sudden cardiac death.

199. Disposition of Comments for CER 178 Newer Medications for Lower Urinary Tract Symptoms (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/prostatic-hyperplasia-medications_disposition-comments.pdf
     May 26, 2016 - Included trials did not report the impact of the combination of these drugs on blood pressure and we … We revised the sentence to clarify: “Recently, newer drugs and drug in other classes approved for … All drugs are FDA-approved and therefore likely to have trials published in English. … We included drugs ‘newly used’ to treat LUTS attributable to BPH. … Drugs with insufficient evidence were added to the anticholinergics paragraph.

200. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/01_-arthritis_potential_high_impact_june_2012.pdf
     January 01, 2012 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Tofacitinib (CP-690,550) in combination with traditional disease-modifying anti- rheumatic drugs: